The expression of mRNA for calcitonin gene-related peptide receptors in a mucosal type mast cell line, RBL-2H3

Biological and Pharmaceutical Bulletin

Volumn 27, Issue 6, 2004, Pages 896-898

  Kitabatake, Yuki ^a   Kawamura, Shunsuke ^a   Yamashita, Masamichi ^a   Okuyama, Kaori ^a   Takayanagi, Motoaki ^a   Ohno, Isao ^a  

^a TOHOKU PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

Adrenomedullin; Calcitonin gene related peptide (CGRP); Calcitonin receptor like receptor (CRLR); Mast cell; RDC 1; Receptor activity modifying protein (RAMP)

Indexed keywords

ADRENOMEDULLIN; CALCITONIN GENE RELATED PEPTIDE; CALCITONIN GENE RELATED PEPTIDE RECEPTOR; CALCITONIN RECEPTOR LIKE RECEPTOR; IMMUNOGLOBULIN E RECEPTOR; MESSENGER RNA; RECEPTOR ACTIVITY MODIFYING PROTEIN; RECEPTOR ACTIVITY MODIFYING PROTEIN 1; RECEPTOR ACTIVITY MODIFYING PROTEIN 2; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; GENE EXPRESSION; MAST CELL LEUKEMIA; NONHUMAN; PATHOPHYSIOLOGY; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ANIMAL; BIOSYNTHESIS; GENE EXPRESSION REGULATION; GENETICS; MAST CELL; METABOLISM; MUCOSA; PHYSIOLOGY; TUMOR CELL LINE;

ANIMALS; CELL LINE, TUMOR; GENE EXPRESSION REGULATION; LEUKEMIA, BASOPHILIC, ACUTE; MAST CELLS; MUCOUS MEMBRANE; RATS; RECEPTORS, CALCITONIN GENE-RELATED PEPTIDE; RNA, MESSENGER;

EID: 16644369297     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.27.896     Document Type: Article

References (22)

1. Wimalawansa S. J., Crit. Rev. Neurobiol., 11, 167-239 (1997).
2. Springer J., Geppetti P., Fischer A., Groneberg D. A., Pulm. Pharm. Ther., 16, 121-130 (2003).
3. Kitamura K., Kangawa K., Kawamoto M., Ichiki Y., Nakamura S., Matsuo H., Eto T., Biochem. Biophys. Res. Commun., 192, 553-560 (1993).
4. Kubo A., Minamino N., Isumi Y., Kangawa K., Dohi K., Matsuo H., FEBS Lett., 426, 233-237 (1998).
5. Kubo A., Minamino N., Isumi Y., Katafuchi T., Kangawa K., Dohi K., Matsuo H., J. Biol. Chem., 273, 16730-16738 (1998).
6. Kapas S., Clark A. J., Biochem. Biophys. Res. Commun., 217, 832-838 (1995).
7. Juaneda C., Dumont Y., Quirion R., Trends Pharmacol. Sci., 21, 432-438 (2000).
8. Libert F., Parmentier M., Lefort A., Dinsart C., Van. Sande J. , Maenhaut C., Simons M. J., Dumont J. E., Vassart G., Science, 244, 569-572 (1989).
9. Collum R. G., Fisher P. E., Datta M., Mellis S., Thiele C., Huebner K., Croce C. M., Israel M. A., Nucleic Acids Res., 20, 4919-4925 (1992).
10. McLatchie L. M., Fraser N. J., Main M. J., Wise A., Brown J., Thompson N., Solari R., Lee M. G., Foord S. M., Nature (London), 393, 333-339 (1998).
11. Boyce J. A., J. Allergy Clin. Immunol., 111, 24-32 (2003).
12. Welle M., J. Leukoc. Biol., 61, 233-245 (1997).
13. Seldin D. C., Adelman S., Austen K. F., Stevens R. L., Hein A., Caulfield J. P., Woodbury R. G., Proc. Natl. Acad. Sci. U.S.A., 82, 3871-3875 (1985).
14. Penner R., Matthews G., Neher E., Nature (London), 334, 499-504 (1988).
15. Lowman M. A., Benyon R. C., Church M. K., Br. J. Pharmacol., 98, 121-130 (1988).
16. Forsythe P., McGarvey L. P., Heaney L. G., MacMahon J., Ennis M., Clin. Exp. Allergy, 30, 225-232 (2000).
17. Ottosson A., Edvinsson L., Cephalalgia, 17, 166-174 (1997).
18. Yoshida M., Yoshida H., Kitaichi K., Hiramatsu K., Kimura T., Ito Y., Kume H., Yamaki K., Suzuki R., Shibata E., Hasegawa T., Takagi K., Regul. Pept., 101, 163-168 (2001).
19. Matsushima M., Kitaichi K., Tatsumi Y., Hasegawa T., Takagi K., Eur. J. Pharmacol., 464, 111-114 (2003).
20. Yamashita M., Kushihara M., Hirasawa N., Takasaki W., Takahagi H., Takayanagi M., Ohuchi K., Br. J. Pharmacol., 129, 367-373 (2000).
21. Qing X., Svaren J., Keith I. M., Am. J. Physiol. Lung. Cell Mol. Physiol., 280, L547-L554 (2001).
22. Robbins M., McKinney M., Brain Res. Mol. Brain Res., 13, 83-92 (1992).